ArticleBMC surgery2025
Total bilirubin level on postoperative day 3 in predicting clinically relevant pancreatic fistula after pancreaticoduodenectomy: a retrospective study.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundCR-POPF following PD are very common. The Majority of research on predicting CR-POPF focuses on pre-operation, while there are few indicators for predicting CR-POPF in the early postoperative period. The purpose of this study was to see how TBIL levels on postoperative day 3 predict CR-POPF after PD.
methodsThe clinical data of 170 patients who had PD in our team between January 2015 and October 2022 were retrospectively analyzed into two groups: the CR-POPF group with a grade B or C pancreatic fistula (n = 37), the no CR-POPF group with a non-pancreatic fistula, and the biochemical fistula patients (n = 133). Univariate and multivariate analyses were used to discover potential determinants of CR-POPF. The predictive value of risk factors was determined by calculating the area under the ROC curve.
resultsPreoperative variables, including Hb, CRP, TBIL, ALB, pancreatic texture, hemorrhage, duct diameter, and TBIL on postoperative day 3, were found to predict clinically relevant postoperative CR-POPF after PD (p < 0.001). The multivariate logistic regression study revealed that pancreatic texture (p = 0.004), postoperative TBIL (p < 0.001), and preoperative CRP (p = 0.048) are independent risk variables. To predict CR-POPF, the AUC of pancreatic texture, TBIL on the third day of surgery, and preoperative CRP were found to be 0.607, 0.824, and 0.726, respectively.
conclusionThe TBIL level on postoperative day 3 is a significant predictor of CR-POPF after PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.